TF name: | FOS |
TF family: | TF_bZIP |
Ensembl gene ID: | ENSG00000170345 |
Ensembl protein ID: | ENSP00000451786, ENSP00000306245, ENSP00000452590, ENSP00000450886, ENSP00000452386 |
Entrez gene ID: | 2353 |
Sample ID | Biosample type | Tissue type | Biosample name | TF Frequency |
---|---|---|---|---|
Sample_01_046 | Cell line | Mammary Gland | MCF-7 | 0.6 |
Sample_02_021 | Cell line | Colon | V429 | 0.01470164312482 |
Sample_02_168 | Cell line | Prostate | LNCaP | 0.30798479087452 |
Sample_02_196 | Cell line | Stomach | NCC59 | 1 |
Sample_02_198 | Cell line | Stomach | SNU16 | 1 |
Sample_02_204 | Cell line | Stomach | IM95 | 0.13636363636364 |
Sample_02_205 | Tissue | Stomach | Gastric_Primary_Sample_T | 0.75555555555556 |
Sample_02_236 | Cell line | Colon | V206 | 0.29192546583851 |
Sample_02_237 | Cell line | Colon | V389 | 0.16624332781152 |
Sample_02_241 | Cell line | Colon | V456 | 0.57562076749436 |
Sample_02_242 | Cell line | Colon | V481 | 0.53883868486829 |
Sample_02_354 | Cell line | Colon | Colo205 | 0.62012012012012 |
Sample_02_356 | Cell line | Colon | Sw480 | 0.69032258064516 |
Sample ID | Tissue type | Biosample type | Biosample name |
---|---|---|---|
Sample_02_196 | Stomach | Cell line | NCC59 |
Sample_02_198 | Stomach | Cell line | SNU16 |
Sample_02_205 | Stomach | Tissue | Gastric_Primary_Sample_T |
Sample_02_241 | Colon | Cell line | V456 |
Sample_02_242 | Colon | Cell line | V481 |
Sample_02_356 | Colon | Cell line | Sw480 |
rsID | Chr | Start | Stop | Ref | Alt | Gene_region | Gene_symble | Effect | TCGA_Occurrence |
---|---|---|---|---|---|---|---|---|---|
rs746175046 | chr14 | 75747586 | 75747586 | G | A | exonic | FOS | nonsynonymous | COAD|1|367|0.00272,COADREAD|1|489|0.00204 |
- | chr14 | 75745716 | 75745716 | G | C | exonic | FOS | nonsynonymous | GBM|1|290|0.00345,GBMLGG|1|820|0.00122 |
- | chr14 | 75745804 | 75745804 | T | C | exonic | FOS | nonsynonymous | HNSC|1|512|0.00195 |
- | chr14 | 75747866 | 75747866 | - | C | exonic | FOS | frameshift | SKCM|1|368|0.00272 |
- | chr14 | 75747935 | 75747935 | C | A | exonic | FOS | synonymous | BLCA|1|396|0.00253 |
rs771351750 | chr14 | 75747297 | 75747297 | G | A | exonic | FOS | nonsynonymous | BLCA|1|396|0.00253,LUSC|1|178|0.00562 |
- | chr14 | 75748065 | 75748065 | - | CA | exonic | FOS | frameshift | BLCA|1|396|0.00253 |
- | chr14 | 75747960 | 75747960 | C | T | exonic | FOS | nonsynonymous | HNSC|1|512|0.00195 |
- | chr14 | 75746765 | 75746765 | T | G | exonic | FOS | synonymous | BRCA|1|982|0.00102 |
- | chr14 | 75746797 | 75746797 | C | T | exonic | FOS | nonsynonymous | UCEC|1|248|0.00403 |
- | chr14 | 75747528 | 75747528 | G | A | exonic | FOS | nonsynonymous | COADREAD|1|489|0.00204,READ|1|122|0.00820 |
- | chr14 | 75747303 | 75747303 | A | - | exonic | FOS | frameshift | COAD|1|367|0.00272,COADREAD|1|489|0.00204 |
- | chr14 | 75747991 | 75747991 | C | A | exonic | FOS | nonsynonymous | UCEC|1|248|0.00403 |
- | chr14 | 75746642 | 75746642 | G | A | exonic | FOS | synonymous | PCPG|1|184|0.00543 |
- | chr14 | 75747717 | 75747717 | A | C | exonic | FOS | nonsynonymous | OV|1|469|0.00213 |
- | chr14 | 75745827 | 75745827 | G | A | splicing | FOS | splicing | BLCA|1|396|0.00253 |
- | chr14 | 75747284 | 75747284 | A | - | exonic | FOS | frameshift | COAD|2|367|0.00545,COADREAD|2|489|0.00409 |
- | chr14 | 75746886 | 75746886 | C | - | intronic | FOS | unknown | THYM|1|123|0.00813 |
- | chr14 | 75747808 | 75747808 | C | A | exonic | FOS | nonsynonymous | LUSC|1|178|0.00562 |
- | chr14 | 75748069 | 75748069 | G | T | exonic | FOS | nonsynonymous | TGCT|1|155|0.00645 |
- | chr14 | 75747713 | 75747713 | C | T | exonic | FOS | synonymous | SKCM|1|368|0.00272 |
- | chr14 | 75748073 | 75748073 | C | T | exonic | FOS | synonymous | BRCA|1|982|0.00102 |
- | chr14 | 75748089 | 75748089 | T | C | exonic | FOS | nonsynonymous | ESCA|1|185|0.00541 |
- | chr14 | 75746726 | 75746726 | C | T | exonic | FOS | synonymous | BLCA|1|396|0.00253 |
- | chr14 | 75747346 | 75747346 | G | A | exonic | FOS | synonymous | SKCM|1|368|0.00272 |
- | chr14 | 75747343 | 75747343 | G | A | exonic | FOS | synonymous | SKCM|1|368|0.00272 |
- | chr14 | 75747933 | 75747933 | G | C | exonic | FOS | nonsynonymous | LUAD|2|543|0.00368 |
- | chr14 | 75746590 | 75746590 | C | T | exonic | FOS | nonsynonymous | KIPAN|2|799|0.00250,KIRC|2|451|0.00443 |
- | chr14 | 75745726 | 75745726 | C | T | exonic | FOS | nonsynonymous | HNSC|1|512|0.00195 |
- | chr14 | 75747676 | 75747676 | C | T | exonic | FOS | nonsynonymous | GBMLGG|1|820|0.00122,LGG|1|530|0.00189 |
- | chr14 | 75746698 | 75746698 | C | G | exonic | FOS | nonsynonymous | HNSC|1|512|0.00195 |
- | chr14 | 75746665 | 75746665 | T | C | exonic | FOS | nonsynonymous | COAD|1|367|0.00272,COADREAD|1|489|0.00204 |
rs764583472 | chr14 | 75748072 | 75748072 | G | A | exonic | FOS | nonsynonymous | UCEC|1|248|0.00403 |
- | chr14 | 75747810 | 75747810 | G | A | exonic | FOS | nonsynonymous | LUAD|1|543|0.00184 |
- | chr14 | 75747272 | 75747272 | G | A | exonic | FOS | nonsynonymous | SKCM|1|368|0.00272 |
- | chr14 | 75747739 | 75747739 | C | T | exonic | FOS | nonsynonymous | CESC|1|194|0.00515 |
- | chr14 | 75747770 | 75747770 | G | T | exonic | FOS | nonsynonymous | BLCA|1|396|0.00253 |
- | chr14 | 75747316 | 75747316 | G | A | exonic | FOS | nonsynonymous | CESC|1|194|0.00515 |
- | chr14 | 75747600 | 75747600 | A | G | exonic | FOS | nonsynonymous | STAD|1|395|0.00253,STES|1|395|0.00253 |
- | chr14 | 75747981 | 75747981 | A | T | exonic | FOS | nonsynonymous | LIHC|1|373|0.00268 |
rs746383613 | chr14 | 75748023 | 75748023 | G | A | exonic | FOS | nonsynonymous | HNSC|1|512|0.00195 |
- | chr14 | 75747998 | 75747998 | G | T | exonic | FOS | synonymous | TGCT|1|155|0.00645 |
- | chr14 | 75747367 | 75747367 | A | C | exonic | FOS | nonsynonymous | HNSC|1|512|0.00195 |
- | chr14 | 75747810 | 75747810 | G | T | exonic | FOS | nonsynonymous | TGCT|1|155|0.00645 |
- | chr14 | 75748078 | 75748078 | A | T | exonic | FOS | nonsynonymous | LUAD|1|543|0.00184 |
TF_name | Disease_name | Disease_class | Disease_semantic_type | TF_disease_source |
---|---|---|---|---|
FOS | Anxiety Disorders | F03 | Mental or Behavioral Dysfunction | CTD_human |
FOS | Cholestasis, Extrahepatic | C06 | Disease or Syndrome | CTD_human |
FOS | Malignant neoplasm of breast | C04;C17 | Neoplastic Process | CTD_human |
FOS | Neoplastic Cell Transformation | C04;C23 | Neoplastic Process | CTD_human |
FOS | Cocaine Abuse | C25;F03 | Mental or Behavioral Dysfunction | CTD_human |
FOS | Lipoatrophic Diabetes Mellitus | C18;C19 | Disease or Syndrome | ORPHANET |
FOS | Endometriosis | C13 | Disease or Syndrome | CTD_human |
FOS | Epilepsy | C10 | Disease or Syndrome | CTD_human |
FOS | Osteitis Fibrosa Disseminata | C05 | Disease or Syndrome | CTD_human |
FOS | Heat Stroke | C26 | Injury or Poisoning | CTD_human |
FOS | Hemorrhage | C23 | Pathologic Function | CTD_human |
FOS | Hyperalgesia | C10;C23 | Sign or Symptom | CTD_human |
FOS | Hypertensive disease | C14 | Disease or Syndrome | CTD_human |
FOS | Jacksonian Seizure | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Liver Cirrhosis, Experimental | C06 | Experimental Model of Disease | CTD_human |
FOS | Lung Neoplasms | C04;C08 | Neoplastic Process | CTD_human |
FOS | nervous system disorder | C10 | Disease or Syndrome | CTD_human |
FOS | Reperfusion Injury | C14;C23 | Injury or Poisoning | CTD_human |
FOS | Seizures | C10;C23 | Sign or Symptom | CTD_human |
FOS | Status Epilepticus | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Substance Withdrawal Syndrome | C25;F03 | Mental or Behavioral Dysfunction | CTD_human |
FOS | Trigeminal Neuralgia | C07;C10 | Disease or Syndrome | CTD_human |
FOS | Unipolar Depression | F03 | Mental or Behavioral Dysfunction | PSYGENET |
FOS | Injuries, Acute Brain | C10;C26 | Injury or Poisoning | CTD_human |
FOS | Drug Withdrawal Symptoms | C25;F03 | Sign or Symptom | CTD_human |
FOS | Epilepsy, Cryptogenic | C10 | Disease or Syndrome | CTD_human |
FOS | Juvenile-Onset Still Disease | C05;C17;C20 | Disease or Syndrome | CTD_human |
FOS | Withdrawal Symptoms | C25;F03 | Sign or Symptom | CTD_human |
FOS | Encephalopathy, Toxic | C10;C25 | Injury or Poisoning | CTD_human |
FOS | Complex partial seizures | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Toxic Encephalitis | C10;C25 | Injury or Poisoning | CTD_human |
FOS | Familial generalized lipodystrophy | C16;C17;C18 | Disease or Syndrome | ORPHANET |
FOS | Generalized seizures | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Seizures, Clonic | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Neurotoxicity Syndromes | C10;C25 | Injury or Poisoning | CTD_human |
FOS | Aura | C10 | Finding | CTD_human |
FOS | Amphetamine-Related Disorders | C25;F03 | Mental or Behavioral Dysfunction | CTD_human |
FOS | Cocaine-Related Disorders | C25;F03 | Mental or Behavioral Dysfunction | CTD_human |
FOS | Amphetamine Addiction | C25;F03 | Mental or Behavioral Dysfunction | CTD_human |
FOS | Amphetamine Abuse | C25;F03 | Mental or Behavioral Dysfunction | CTD_human |
FOS | Middle Cerebral Artery Syndrome | C10;C14 | Disease or Syndrome | CTD_human |
FOS | Malignant neoplasm of lung | C04;C08 | Neoplastic Process | CTD_human |
FOS | Endometrioma | C13 | Neoplastic Process | CTD_human |
FOS | Brain Injuries | C10;C26 | Injury or Poisoning | CTD_human |
FOS | Petit mal status | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Visual seizure | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Tonic Seizures | C10;C23 | Sign or Symptom | CTD_human |
FOS | Epileptic drop attack | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Brain Lacerations | C10;C26 | Injury or Poisoning | CTD_human |
FOS | Grand Mal Status Epilepticus | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Anxiety States, Neurotic | F03 | Mental or Behavioral Dysfunction | CTD_human |
FOS | Complex Partial Status Epilepticus | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Trigeminal Neuralgia, Idiopathic | C07;C10 | Disease or Syndrome | CTD_human |
FOS | Secondary Trigeminal Neuralgia | C07;C10 | Disease or Syndrome | CTD_human |
FOS | Seizures, Somatosensory | C10;C23 | Pathologic Function | CTD_human |
FOS | Seizures, Auditory | C10;C23 | Pathologic Function | CTD_human |
FOS | Olfactory seizure | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Gustatory seizure | C10;C23 | Sign or Symptom | CTD_human |
FOS | Vertiginous seizure | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Hyperactive behavior | C10;C23 | Mental or Behavioral Dysfunction | CTD_human |
FOS | Brain Injuries, Focal | C10;C26 | Injury or Poisoning | CTD_human |
FOS | Allodynia | C10;C23 | Finding | CTD_human |
FOS | Tonic - clonic seizures | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Cocaine Dependence | C25;F03 | Mental or Behavioral Dysfunction | CTD_human |
FOS | Breast Carcinoma | C04;C17 | Neoplastic Process | CTD_human |
FOS | Middle Cerebral Artery Thrombosis | C10;C14 | Disease or Syndrome | CTD_human |
FOS | Middle Cerebral Artery Occlusion | C10;C14 | Acquired Abnormality | CTD_human |
FOS | Infarction, Middle Cerebral Artery | C10;C14 | Disease or Syndrome | CTD_human |
FOS | Non-epileptic convulsion | C10;C23 | Sign or Symptom | CTD_human |
FOS | Single Seizure | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Awakening Epilepsy | C10 | Disease or Syndrome | CTD_human |
FOS | Atonic Absence Seizures | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Hyperalgesia, Primary | C10;C23 | Sign or Symptom | CTD_human |
FOS | Hyperalgesia, Secondary | C10;C23 | Sign or Symptom | CTD_human |
FOS | Tactile Allodynia | C10;C23 | Sign or Symptom | CTD_human |
FOS | Hyperalgesia, Thermal | C10;C23 | Sign or Symptom | CTD_human |
FOS | Hyperkinesia, Generalized | C10;C23 | Sign or Symptom | CTD_human |
FOS | Convulsive Seizures | C10;C23 | Sign or Symptom | CTD_human |
FOS | Seizures, Focal | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Seizures, Sensory | C10;C23 | Sign or Symptom | CTD_human |
FOS | Status Epilepticus, Subclinical | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Non-Convulsive Status Epilepticus | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Simple Partial Status Epilepticus | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Middle Cerebral Artery Embolus | C10;C14 | Disease or Syndrome | CTD_human |
FOS | Left Middle Cerebral Artery Infarction | C10;C14 | Disease or Syndrome | CTD_human |
FOS | Embolic Infarction, Middle Cerebral Artery | C10;C14 | Disease or Syndrome | CTD_human |
FOS | Thrombotic Infarction, Middle Cerebral Artery | C10;C14 | Disease or Syndrome | CTD_human |
FOS | Right Middle Cerebral Artery Infarction | C10;C14 | Disease or Syndrome | CTD_human |
FOS | Mammary Neoplasms, Human | C04;C17 | Neoplastic Process | CTD_human |
FOS | Major Depressive Disorder | F03 | Mental or Behavioral Dysfunction | PSYGENET |
FOS | Anxiety neurosis (finding) | F03 | Mental or Behavioral Dysfunction | CTD_human |
FOS | Mammary Neoplasms | C04;C17 | Neoplastic Process | CTD_human |
FOS | AMYOTROPHIC LATERAL SCLEROSIS 1 | C10;C18 | Disease or Syndrome | CTD_human |
FOS | Amyotrophic Lateral Sclerosis, Sporadic | C10;C18 | Disease or Syndrome | CTD_human |
FOS | Liver carcinoma | C04;C06 | Neoplastic Process | CTD_human |
FOS | Mechanical Allodynia | C10;C23 | Sign or Symptom | CTD_human |
FOS | Juvenile arthritis | C05;C17;C20 | Disease or Syndrome | CTD_human |
FOS | Nonepileptic Seizures | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Juvenile psoriatic arthritis | C05;C17;C20 | Disease or Syndrome | CTD_human |
FOS | Convulsions | C10;C23 | Sign or Symptom | CTD_human |
FOS | Familial M?ni?re disease | Disease or Syndrome | GENOMICS_ENGLAND | |
FOS | Absence Seizures | C10;C23 | Sign or Symptom | CTD_human |
FOS | Epileptic Seizures | C10;C23 | Disease or Syndrome | CTD_human |
FOS | Myoclonic Seizures | C10;C23 | Sign or Symptom | CTD_human |
FOS | Generalized Absence Seizures | C10;C23 | Disease or Syndrome | CTD_human |
pathway_ID | pathway_name | pathway_source | gene_number | edge_number |
---|---|---|---|---|
pathway0000080 | Activation of the AP-1 family of transcription factors | reactome | 10 | 35 |
pathway0000147 | Alpha6Beta4Integrin | netpath | 74 | 899 |
pathway0000177 | Angiogenesis | panther | 141 | 2497 |
pathway0000187 | AP-1 transcription factor network | pid | 71 | 659 |
pathway0000196 | Apoptosis signaling pathway | panther | 104 | 1308 |
pathway0000229 | ATF-2 transcription factor network | pid | 59 | 451 |
pathway0000265 | B cell activation | panther | 52 | 541 |
pathway0000271 | BCR signaling pathway | pid | 70 | 890 |
pathway0000343 | Calcineurin-regulated NFAT-dependent transcription in lymphocytes | pid | 50 | 304 |
pathway0000347 | Calcium signaling in the CD4+ TCR pathway | pid | 29 | 153 |
pathway0000634 | Downstream signaling in nave CD8+ T cells | pid | 69 | 708 |
pathway0000669 | Endothelins | pid | 64 | 750 |
pathway0000692 | ErbB1 downstream signaling | pid | 105 | 1597 |
pathway0000695 | ErbB2/ErbB3 signaling events | pid | 41 | 404 |
pathway0000767 | Fc-epsilon receptor I signaling in mast cells | pid | 64 | 826 |
pathway0000771 | FCERI mediated MAPK activation | reactome | 40 | 456 |
pathway0000780 | FGF signaling pathway | pid | 55 | 600 |
pathway0000824 | FOXA1 transcription factor network | pid | 45 | 204 |
pathway0000826 | FOXM1 transcription factor network | pid | 43 | 294 |
pathway0000895 | Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling (JNK cascade) ) | inoh | 5 | 10 |
pathway0000896 | Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling ) | inoh | 5 | 10 |
pathway0000916 | Glucocorticoid receptor regulatory network | pid | 85 | 876 |
pathway0000966 | GMCSF-mediated signaling events | pid | 38 | 413 |
pathway0001021 | HIF-1-alpha transcription factor network | pid | 67 | 420 |
pathway0001116 | IL12-mediated signaling events | pid | 62 | 684 |
pathway0001117 | IL12 signaling mediated by STAT4 | pid | 33 | 229 |
pathway0001119 | IL2-mediated signaling events | pid | 54 | 871 |
pathway0001131 | IL6-mediated signaling events | pid | 48 | 426 |
pathway0001132 | IL6 | netpath | 85 | 1335 |
pathway0001166 | Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade | panther | 29 | 156 |
pathway0001191 | Interleukin signaling pathway | panther | 86 | 1548 |
pathway0001230 | JNK cascade ( CD4 T cell receptor signaling (JNK cascade) ) | inoh | 12 | 48 |
pathway0001231 | JNK cascade ( CD4 T cell receptor signaling ) | inoh | 10 | 35 |
pathway0001295 | LPA receptor mediated events | pid | 65 | 700 |
pathway0001507 | Nongenotropic Androgen signaling | pid | 31 | 254 |
pathway0001554 | Osteopontin-mediated events | pid | 32 | 226 |
pathway0001559 | Oxidative Stress Induced Senescence | reactome | 120 | 3580 |
pathway0001604 | PDGF signaling pathway | panther | 113 | 1684 |
pathway0001605 | PDGFR-alpha signaling pathway | pid | 22 | 96 |
pathway0001606 | PDGFR-beta signaling pathway | pid | 125 | 2449 |
pathway0001714 | Presenilin action in Notch and Wnt signaling | pid | 46 | 287 |
pathway0001727 | Prolactin | netpath | 105 | 1733 |
pathway0001806 | Ras signaling in the CD4+ TCR pathway | pid | 14 | 58 |
pathway0001849 | Regulation of nuclear SMAD2/3 signaling | pid | 82 | 1072 |
pathway0001861 | Regulation of Telomerase | pid | 70 | 708 |
pathway0001903 | RhoA signaling pathway | pid | 46 | 233 |
pathway0001950 | S1P2 pathway | pid | 26 | 167 |
pathway0001980 | Senescence-Associated Secretory Phenotype (SASP) | reactome | 108 | 2712 |
pathway0002183 | T cell activation | panther | 60 | 903 |
pathway0002217 | TGF-beta signaling pathway | panther | 88 | 1636 |
pathway0002273 | TP53 Regulates Transcription of DNA Repair Genes | reactome | 61 | 1425 |
pathway0002340 | Trk receptor signaling mediated by the MAPK pathway | pid | 34 | 175 |
pathway0002390 | Validated targets of C-MYC transcriptional activation | pid | 80 | 573 |
pathway0002392 | Validated transcriptional targets of AP1 family members Fra1 and Fra2 | pid | 37 | 165 |
pathway0002393 | Validated transcriptional targets of deltaNp63 isoforms | pid | 47 | 101 |
pathway0002657 | Colorectal cancer | kegg | 63 | 642 |
pathway0002699 | Hs_Corticotropin-releasing_hormone_signaling_pathway_WP2355_90017 | wikipathways | 41 | 162 |
pathway0002742 | Hs_Serotonin_and_anxiety-related_events_WP3944_90836 | wikipathways | 9 | 12 |
pathway0002754 | Hs_Structural_Pathway_of_Interleukin_1_(IL-1)_WP2637_87707 | wikipathways | 34 | 195 |
pathway0002760 | Hs_Oncostatin_M_Signaling_Pathway_WP2374_73668 | wikipathways | 44 | 408 |
pathway0002811 | Hs_Estrogen_signaling_pathway_WP712_78491 | wikipathways | 13 | 57 |
pathway0002837 | Hs_IL-5_Signaling_Pathway_WP127_78498 | wikipathways | 35 | 321 |
pathway0002864 | Hs_IL-4_Signaling_Pathway_WP395_89828 | wikipathways | 41 | 397 |
pathway0002871 | Hs_IL-3_Signaling_Pathway_WP286_78583 | wikipathways | 35 | 403 |
GO_term_name | GO_term_type | TF_name |
---|---|---|
GO_SMAD_PROTEIN_SIGNAL_TRANSDUCTION | BP | FOS |
GO_NEUROLOGICAL_SYSTEM_PROCESS | BP | FOS |
GO_MUSCLE_TISSUE_DEVELOPMENT | BP | FOS |
GO_RESPONSE_TO_ORGANOPHOSPHORUS | BP | FOS |
GO_SINGLE_ORGANISM_BEHAVIOR | BP | FOS |
GO_RESPONSE_TO_MUSCLE_STRETCH | BP | FOS |
GO_RESPONSE_TO_COLD | BP | FOS |
GO_RESPONSE_TO_STEROID_HORMONE | BP | FOS |
GO_RESPONSE_TO_IMMOBILIZATION_STRESS | BP | FOS |
GO_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION | BP | FOS |
GO_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION | BP | FOS |
GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS | BP | FOS |
GO_RESPONSE_TO_GRAVITY | BP | FOS |
GO_PLACENTA_BLOOD_VESSEL_DEVELOPMENT | BP | FOS |
GO_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION | BP | FOS |
GO_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION | BP | FOS |
GO_REGULATION_OF_HEMOPOIESIS | BP | FOS |
GO_IN_UTERO_EMBRYONIC_DEVELOPMENT | BP | FOS |
GO_KERATINOCYTE_DIFFERENTIATION | BP | FOS |
GO_POSITIVE_REGULATION_OF_PRI_MIRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER | BP | FOS |
GO_RESPONSE_TO_CAMP | BP | FOS |
GO_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION | BP | FOS |
GO_REGULATION_OF_FIBROBLAST_PROLIFERATION | BP | FOS |
GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION | BP | FOS |
GO_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND | BP | FOS |
GO_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY | BP | FOS |
GO_POSITIVE_REGULATION_OF_CELL_DEATH | BP | FOS |
GO_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION | BP | FOS |
GO_RESPONSE_TO_PROGESTERONE | BP | FOS |
GO_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY | BP | FOS |
GO_RESPONSE_TO_CORTICOSTERONE | BP | FOS |
GO_CELLULAR_RESPONSE_TO_CALCIUM_ION | BP | FOS |
GO_DNA_METHYLATION_OR_DEMETHYLATION | BP | FOS |
GO_RESPONSE_TO_GROWTH_FACTOR | BP | FOS |
GO_FEMALE_GAMETE_GENERATION | BP | FOS |
GO_SLEEP | BP | FOS |
GO_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION | BP | FOS |
GO_RESPONSE_TO_MINERALOCORTICOID | BP | FOS |
GO_PLACENTA_DEVELOPMENT | BP | FOS |
GO_FEEDING_BEHAVIOR | BP | FOS |
GO_REGULATION_OF_PRI_MIRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER | BP | FOS |
GO_EPITHELIAL_CELL_DIFFERENTIATION | BP | FOS |
GO_RESPONSE_TO_ALCOHOL | BP | FOS |
GO_RESPONSE_TO_ISOQUINOLINE_ALKALOID | BP | FOS |
GO_RESPONSE_TO_MECHANICAL_STIMULUS | BP | FOS |
GO_CELLULAR_DEFENSE_RESPONSE | BP | FOS |
GO_RESPONSE_TO_PURINE_CONTAINING_COMPOUND | BP | FOS |
GO_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION | BP | FOS |
GO_RESPONSE_TO_HYDROGEN_PEROXIDE | BP | FOS |
GO_DNA_ALKYLATION | BP | FOS |
GO_RESPONSE_TO_CALCIUM_ION | BP | FOS |
GO_SYNAPSE | CC | FOS |
GO_PRESYNAPTIC_MEMBRANE | CC | FOS |
GO_TRANSCRIPTIONAL_ACTIVATOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_BINDING | MF | FOS |
GO_R_SMAD_BINDING | MF | FOS |
GO_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_ACTIVITY_SEQUENCE_SPECIFIC_DNA_BINDING | MF | FOS |
GO_DOUBLE_STRANDED_DNA_BINDING | MF | FOS |
GO_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING | MF | FOS |
GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING | MF | FOS |
GO_CHROMATIN_BINDING | MF | FOS |
GO_CORE_PROMOTER_PROXIMAL_REGION_DNA_BINDING | MF | FOS |